Top news of the week: 04.08.2021.
Companies And Industries
Three Biopharma Companies Made Public Debut on Nasdaq Exchange
Nuvalent, Rallybio and Icosavax all began selling on the Nasdaq Exchange today.
Japan’s volatile policy direction continues as challenge, but R&D remains strong
Rapid changes, a traditionally conservative approach and a chronic lack of regulatory transparency could undo a lot of the progress that Japan has made in the past few years to speed up ...
Danaher Delivers: Cytiva, Pall Plan $1.5B Manufacturing Expansion
Biopharma’s ongoing quest to develop COVID-19 drugs and vaccines, plus growing industry demand for producing various types of new therapies, are fueling the $1.5-billion expansion of ...
IGM poaches Gilead cancer chief Takimoto at pivotal moment for both companies
IGM Biosciences has lured away Gilead’s oncology chief Chris Takimoto, M.D., Ph.D., to become chief medical officer, where he will oversee a pipeline of early-stage cancer assets. ...
Takeda allies with Frazier to spin out late-phase norovirus vaccinei
Takeda has spun out its norovirus vaccine prospect to create a biotech: HilleVax. Frazier Healthcare Partners has teamed up with Takeda to found HilleVax, providing investor support for a ...
Find my institution
Barley (Hordeum vulgare) is the fourth most cultivated crop in the world in terms of production volume, and it is also the most important raw material of the malting and brewing industries. ...
Another day, another billion-dollar deal for PeptiDream, this time with Alnylam
Apparently a licensing agreement with Takeda worth a potential $3.5 billion wasn’t enough for PeptiDream this week. The biopharmaceutical company, which has a peptide-based drug discovery ...
People of color want to participate in Alzheimer's research. The NIA has a new tool to make it happen
The newly approved Alzheimer's disease drug Aduhelm was tested in mostly white individuals, and yet the disease disproportionately impacts people of color. The National Institute on Aging ...